Linzess

Chemical Namelinaclotide
Dosage FormCapsule (oral; 72 mcg, 145mcg, 290 mcg)
Drug ClassReceptor agonists
SystemDigestive
CompanyAllergan
Approval Year2012

Indication

  • For the treatment of irritable bowel syndrome with constipation (IBS-C) in adults
  • For the treatment of chronic idiopathic constipation in adults
Last updated on 4/21/2022

More on this drug: Clinical Trials

Document TitleYearSource
Linzess (linaclotide) Prescribing Information.2012Allergan USA Inc., Irvine, CA
Document TitleYearSource
Assessment report: Constella. 2019EMA

Have we missed a study, or would you like to comment on a study?